Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant

Chest

Volumn 115, Issue 2, 1999, Pages 403-409

  Henke, Jonathan A ^a   Golden, Jeffrey A ^a,b   Yelin, Edward H ^a   Keith, Fraser A ^a   Blanc, Paul D ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Bronchoalveolar lavage; Bronchoscopy; Lung transplant; Neutrophils; Transbronchial biopsy

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; EMPHYSEMA; FEMALE; FIBEROPTIC BRONCHOSCOPY; FIBROSING ALVEOLITIS; HUMAN; LUNG DISEASE; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; NEUTROPHIL; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY;

EID: 0032909735     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.2.403     Document Type: Article

References (27)

1. Hosenpud JD, Bennet LE, Keck BS, et al. Registry of the international society for heart and lung transplantation: 14th official report - 1997. J Heart Lung Transplant 1997; 16:691-712
2. Scott JP, Peters SG, McDougall JC, et al. Posttransplantation physiologic features of the lung and obliterative bronchiolitis. Mayo Clin Proc 1997; 72:170-174
3. Husain AN, Siddiqui MT, Montoya A, et al. Post lung-transplant biopsies: an 8-year Loyola experience. Mod Pathol 1996; 9:126-132
4. Kukafka DS, O'Brien GM, Furukawa S, et al. Surveillance bronchoscopy in lung transplant recipients. Chest 1997; 111:377-381
5. Kesten S, Chamberlain D, Maurer J. Yield of surveillance transbronchial biopsies performed beyond 2 years after lung transplantation. J Heart Lung Transplant 1996; 15:384-388
6. Sibley RK, Berry GJ, Tazelaar HD, et al. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant 1993; 12:308-324
7. Clelland C, Higenbottam T, Stewart S, et al. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Am Rev Respir Dis 1993; 147:1386-1392
8. Riise GC, Kjellström C, Ryd W, et al. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study. Eur Respir J 1997; 10:1742-1746
9. Trulock EP, Ettinger NA, Brunt EM, et al. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. Chest 1992; 102:1049-1054
10. Kramer MR, Stoehr C, Whang JL, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993; 12:675-681
11. Yousem SA, Paradis I, Griffith BP. Can transbronchial biopsy aid the diagnosis of bronchiolitis obliterans in lung transplant recipients? Transplantation 1994; 57:151-153
12. Golden JA, Hollander H, Stulbarg MS, et al. Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia, a prospective study among patients with acquired immunodeficiency syndrome. Chest 1986; 90:18-22
13. Sharples LD, Tamm M, McNeil K, et al. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation - early risk factors. Transplantation 1996; 61:560-566
14. Yousem SA, Berry GJ, Brundt EM, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Transplant 1990; 9:593-601
15. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136:1285-1298
16. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12:713-716
17. Girgis RE, Reichenspurner H, Robbins RC, et al. The utility of annual surveillance bronchoscopy in heart-lung transplant recipients. Transplantation 1995; 60:1458-1461
18. Chamberlain D, Maurer J, Chaparro C, et al. Evaluation of transbronchial biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 1994; 13:963-971
19. Guilinger RA, Paradis IL, Dauber JH, et al. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am J Respir Crit Care Med 1995; 152:2037-2043
20. Boehler A, Vogt P, Zollinger A, et al. Prospective study of the value of transbronchial lung biopsy after lung transplantation. Eur Respir J 1996; 9:658-662
21. Baz MA, Layish DT, Govert JA, et al. Diagnostic yield of bronchoscopies after isolated lung transplantation. Chest 1996; 110:84-88
22. Whitehead BF, Stoehr C, Finkle C, et al. Analysis of bronchoalveolar lavage from human lung transplant recipients by flow cytometry. Respir Med 1995; 89:27-34
23. Shennib H, Lee AG, Serrick C, et al. Altered nonspecific lymphocyte cytoxicity in bronchoalveolar lavage of lung-transplant recipients. Transplantation 1996; 62:1262-1267
24. DiGiovine B, Lynch JP III, Martinez FJ, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 1996; 157:4194-4202
25. Masri MA, Stephan A, Barbari A, et al. Correlation between cyclosporine pharmakokinetics and immunologic parameters in dialyzed patients awaiting transplantation. Transplant Proc 1997; 29:2953-2954
26. Bando K, Paradis IL, Similo S, et al. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg 1995; 110:4-13
27. Trulock EP. Management of lung transplant rejection. Chest 1993; 103:1566-1576